CRISPR Therapeutics (NasdaqGM:CRSP) recently announced the departure of Chief Operating Officer Julianne Bruno, reflecting a notable leadership change that could influence its operational direction.

Under the new collaboration, OpenFold will produce a fine-tuned version of its model that’s trained on AbbVie and Johnson & ...

The therapy, EPI-321, is intended to treat cases of facioscapulohumeral muscular dystrophy, a genetic neuromuscular disorder.

With the citrus industry at a crossroads, growers are looking for any solution to cope with the deadly citrus greening ...

In a medical first, a research team in China has successfully stitched a CRISPR gene-edited pig liver into a brain-dead ...

This study achieved CRISPR/Cas9-mediated genome editing in grass carp (Ctenopharyngodon idella), China's most economically vital freshwater fish.

He Jiankui stands by a controversial research approach that landed him in prison as he aims to tackle Alzheimer’s disease.

We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr ...